CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,309	64,095	49,324	62,060	13,255
Short-Term Investments	67,000	-	-	18,020	-
Trading Asset Securities	-	-	-	-	26,020
Cash & Short-Term Investments	75,309	64,095	49,324	80,080	39,275
Cash Growth	17.50%	29.95%	-38.41%	103.89%	26.35%
Accounts Receivable	72.57	160.91	303.82	233.62	99.46
Other Receivables	623.2	178.66	523.06	474.16	257.47
Receivables	695.77	339.57	826.88	707.78	356.93
Inventory	128.75	157.82	76.16	145.83	364.31
Prepaid Expenses	294.56	355.71	446.57	259.18	499.9
Other Current Assets	333.6	262.22	258.72	362.03	592.63
Total Current Assets	76,762	65,210	50,932	81,555	41,089
Property, Plant & Equipment	8,907	12,707	14,364	9,856	19,991
Long-Term Investments	2	2	2	0	-
Other Intangible Assets	12,499	12,397	1,016	114.13	103.95
Other Long-Term Assets	1,439	811.16	25,075	24,830	12,178
Total Assets	99,610	91,128	91,389	116,355	73,362
Accounts Payable	220.83	122.82	336.65	287.75	708.93
Accrued Expenses	3,234	3,966	3,996	140.94	169.76
Short-Term Debt	6,365	3,971	23,588	18,441	-
Current Portion of Leases	1,824	1,869	1,547	1,361	205.9
Other Current Liabilities	6,882	4,793	5,511	3,606	1,919
Total Current Liabilities	18,525	14,722	34,979	23,836	3,004
Long-Term Debt	-	-	-	-	35,081
Long-Term Leases	1,162	2,692	3,831	4,088	479.37
Other Long-Term Liabilities	2,166	2,152	2,924	577.4	314.4
Total Liabilities	21,853	19,633	41,734	28,502	38,878
Common Stock	6,533	4,556	2,939	2,937	1,946
Additional Paid-In Capital	189,419	151,426	108,066	112,186	40,993
Retained Earnings	-119,067	-85,951	-62,738	-28,035	-8,763
Comprehensive Income & Other	872.04	1,465	1,389	765.25	307.61
Shareholders' Equity	77,757	71,496	49,655	87,853	34,484
Total Liabilities & Equity	99,610	91,128	91,389	116,355	73,362
Total Debt	9,351	8,533	28,966	23,891	35,766
Net Cash (Debt)	65,958	55,562	20,357	56,190	3,509
Net Cash Growth	18.71%	172.93%	-63.77%	1501.15%	-88.44%
Net Cash Per Share	7111.76	7843.75	3463.50	13214.21	908.96
Filing Date Shares Outstanding	13.07	9.11	5.88	5.87	3.89
Total Common Shares Outstanding	13.07	9.11	5.88	5.87	3.89
Working Capital	58,236	50,488	15,953	57,718	38,085
Book Value Per Share	5951.30	7845.89	8446.71	14957.10	8859.45
Tangible Book Value	65,257	59,098	48,640	87,739	34,380
Tangible Book Value Per Share	4994.63	6485.40	8273.89	14937.67	8832.74
Land	-	-	-	-	13,973
Buildings	-	-	-	-	2,563
Machinery	14,051	13,686	10,339	4,411	3,488
Construction In Progress	-	-	521.7	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.